Post-marketing surveillance of medicines is essential to detect previously unnoticed adverse effects of treatment. The science of this process is called pharmacovigilance and has been defined as the study of the safety of marketed drugs under the practical conditions of clinical use in large communities. Pharmacovigilance is concerned with the detection, assessment and prevention of adverse effects or any other possible drug-related problems, with the ultimate goal of achieving rational and safe therapeutic decisions in clinical practice.

Report Pharmacovigilance